According to Zhitong Finance App News, Yingpai Pharmaceutical-B (07630.HK) issued an announcement. The board of directors has decided to buy back the company's H shares from time to time on the Hong Kong Stock Exchange Limited open market in accordance with the general authorization granted to the company's shareholders at the annual shareholders' meeting held on June 25, 2026. The total amount shall not exceed HK$100 million (including transaction costs such as brokerage commissions and stamp duties).

According to Zhitong Finance App News, Yingpai Pharmaceutical-B (07630.HK) issued an announcement. The board of directors has decided to buy back the company's H shares from time to time on the Hong Kong Stock Exchange Limited open market in accordance with the general authorization granted to the company's shareholders at the annual shareholders' meeting held on June 25, 2026. The total amount shall not exceed HK$100 million (including transaction costs such as brokerage commissions and stamp duties).